Stockscreener 앱 받기
10.49
1.75%
0.18
전일 마감가:
$10.31
열려 있는:
$10.31
하루 거래량:
173.14K
Relative Volume:
0.66
시가총액:
$364.39M
수익:
$51.00M
순이익/손실:
$-8.73M
주가수익비율:
-35.42
EPS:
-0.2962
순현금흐름:
$-7.75M
1주 성능:
-1.96%
1개월 성능:
+20.57%
6개월 성능:
+35.01%
1년 성능:
+16.04%
1일 변동 폭
$10.08
$10.61
1주일 범위
$10.04
$10.95
52주 변동 폭
$5.65
$11.31
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
명칭
Fennec Pharmaceuticals Inc
전화
(919) 636-4530
주소
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Compare FENC vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
10.49 | 364.39M | 51.00M | -8.73M | -7.75M | -0.2962 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-12 | 개시 | B. Riley Securities | Buy |
| 2026-01-09 | 개시 | Piper Sandler | Overweight |
| 2022-11-22 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2022-09-07 | 개시 | CapitalOne | Overweight |
| 2022-08-08 | 재개 | Craig Hallum | Buy |
| 2020-06-05 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-10-11 | 개시 | Goldman | Buy |
모두보기
Fennec Pharmaceuticals Inc 주식(FENC)의 최신 뉴스
Why Fennec Pharmaceuticals Inc stock is plummeting today - Wealth Awesome
Fennec Pharmaceuticals Company Profile & Introduction - Moomoo
Fennec (NASDAQ: FENC) ex-director exercises options, sells shares for taxes - Stock Titan
Form 144 FENNEC PHARMACEUTICALS INC. For: 1 July By Investing.com - Investing.com India
Fennec Pharmaceuticals (FENC) CCO receives 168-share award, holds 21,183 - Stock Titan
Fennec (NASDAQ: FENC) CMO awarded 168 shares, holds 21,183 - Stock Titan
Fennec Pharmaceuticals (NASDAQ: FENC) CEO reports 1,159-share award release - Stock Titan
FENNEC (FENC) CFO Andrade gains 1,703 vested shares, now holds 290,972 - Stock Titan
Fennec (NASDAQ: FENC) Chief Strategy Officer receives 156-share stock award - Stock Titan
FENC (NASDAQ: FENC) plans 9,599-share option sale; prior small sales listed - Stock Titan
Fennec Pharmaceuticals Inc.(NasdaqCM:FENC) dropped from Russell 2000 Value Benchmark - marketscreener.com
Fennec Pharmaceuticals Inc.(NasdaqCM:FENC) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Fennec Pharmaceuticals Inc.(NasdaqCM:FENC) dropped from Russell 2500 Value Benchmark - marketscreener.com
Enterprise value to EBITDA forward of Fennec Pharmaceuticals Inc. – NASDAQ:FENC - TradingView
Enterprise value to EBIT forward of Fennec Pharmaceuticals Inc. – NASDAQ:FENC - TradingView
Fennec Pharmaceuticals Hits Day High with 13.96% Surge in Stock Price - MarketsMojo
Enterprise value to EBIT forward of Fennec Pharmaceuticals Inc. – FWB:RV41 - TradingView
Enterprise value to EBITDA forward of Fennec Pharmaceuticals Inc. – FWB:RV41 - TradingView
Price to earnings forward of Fennec Pharmaceuticals Inc. – NASDAQ:FENC - TradingView
Fennec Pharmaceuticals Inc. Actuals & Estimates (TSX:FRX) - TradingView
RV41 Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Fennec Pharmaceuticals Inc. – NASDAQ:FENC - TradingView
Price to book forward of Fennec Pharmaceuticals Inc. – NASDAQ:FENC - TradingView
Fennec Pharmaceuticals Inc. Actuals & Estimates (LS:A12A5F) - TradingView
Enterprise value to revenue forward of Fennec Pharmaceuticals Inc. – NASDAQ:FENC - TradingView
Fennec Pharmaceuticals Inc. Actuals & Estimates (BOATS:FENC) - TradingView
FENC Forecast — Price Target — Prediction for 2027 - TradingView
A12A5F Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of Fennec Pharmaceuticals Inc. – BOATS:FENC - TradingView
Price to earnings forward of Fennec Pharmaceuticals Inc. – BOATS:FENC - TradingView
Enterprise value to EBIT forward of Fennec Pharmaceuticals Inc. – BOATS:FENC - TradingView
Why Fennec Pharmaceuticals Inc stock is skyrocketing today - Wealth Awesome
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Fennec Pharmaceuticals (FENC) Gains Ground, Testing Near-Term ResistanceAnalyst Upgrade Stocks - dars.gov.et
Precision Trading with Fennec Pharmaceuticals Inc. (FENC) Risk Zones - Stock Traders Daily
Why Fennec Pharmaceuticals Inc stock is tanking today - Wealth Awesome
Fennec Pharmaceuticals Inc (FENC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Fennec Pharmaceuticals Inc (FENC) Institutional Confidence - TradingKey
Why Fennec Pharmaceuticals Inc stock is gaining today - Wealth Awesome
Fennec Pharmaceuticals Inc - TradingKey
Fennec Pharmaceuticals Inc (FENC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Fennec Pharmaceuticals Inc (FENC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Why Fennec Pharmaceuticals Inc stock is rising today - Wealth Awesome
Fennec Pharmaceuticals Inc (FENC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Fennec Pharmaceuticals Inc (FENC) Valuation: PE, PB & Fair Value Analysis - TradingKey
Fennec Pharmaceuticals Inc (FENC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Fennec Pharmaceuticals Inc (FENC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Fennec Pharmaceuticals Announces Inducement Grants under Nasdaq Listing Rule 5635(4) - marketscreener.com
Fennec Pharmaceuticals : Announces Results of Annual Meeting - marketscreener.com
New Fennec hire gets 10,000 stock options at $9, 10-year term - Stock Titan
FENC Q1 2026 Earnings: Surprise Profit as EPS of $0.01 Beats Estimates by 217.65%EPS Growth Report - newsline.com
Fennec Pharmaceuticals Inc (FENC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Fennec Pharmaceuticals Inc 주식 (FENC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Raykov Rosty | Former Director |
Jul 01 '26 |
Sale |
10.41 |
9,599 |
99,926 |
138,855 |
2.64%
자본화:
|
볼륨(24시간):